Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 934657, 4 pages
Case Report

Invasive Salmonellosis by the Very Rare Salmonella choleraesuis in a Returning Traveler on a Tumor Necrosis Factor-α Inhibitor

1Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
2Department of Infectious Diseases, St. Francis Hospital, Hartford, CT 06105, USA
3Department of Microbiology, St. Francis Hospital, Hartford, CT 06105, USA

Received 26 September 2013; Accepted 3 January 2014; Published 23 February 2014

Academic Editor: Stephen A. Klotz

Copyright © 2014 Uzoamaka A. Eke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Salmonella choleraesuis is one of the least commonly reported nontyphoidal salmonellae in the United States, accounting for only 0.08% and ranking lower than 20th place among all human source salmonellosis reported to the CDC in 2009. In the state of Connecticut, only 12 cases have been reported since 1998 and our case is the only case since 2008. We report a case of invasive Salmonellosis caused by Salmonella choleraesuis in a patient on an antitumor necrosis factor-α agent (adalimumab) who recently returned from a trip to the Dominican Republic.